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Abstract
Populations of human cytomegalovirus (HCMV), a large DNA virus, are highly polymorphic in patient samples, which may
allow for rapid evolution within human hosts. To understand HCMV evolution, longitudinally sampled genomic populations
from the urine and plasma of 5 infants with symptomatic congenital HCMV infection were analyzed. Temporal and
compartmental variability of viral populations were quantified using high throughput sequencing and population genetics
approaches. HCMV populations were generally stable over time, with ,88% of SNPs displaying similar frequencies.
However, samples collected from plasma and urine of the same patient at the same time were highly differentiated with
approximately 1700 consensus sequence SNPs (1.2% of the genome) identified between compartments. This inter-
compartment differentiation was comparable to the differentiation observed in unrelated hosts. Models of demography
(i.e., changes in population size and structure) and positive selection were evaluated to explain the observed patterns of
variation. Evidence for strong bottlenecks (.90% reduction in viral population size) was consistent among all patients. From
the timing of the bottlenecks, we conclude that fetal infection occurred between 13–18 weeks gestational age in patients
analyzed, while colonization of the urine compartment followed roughly 2 months later. The timing of these bottlenecks is
consistent with the clinical histories of congenital HCMV infections. We next inferred that positive selection plays a small but
measurable role in viral evolution within a single compartment. However, positive selection appears to be a strong and
pervasive driver of evolution associated with compartmentalization, affecting $34 of the 167 open reading frames (,20%)
of the genome. This work offers the most detailed map of HCMV in vivo evolution to date and provides evidence that viral
populations can be stable or rapidly differentiate, depending on host environment. The application of population genetic
methods to these data provides clinically useful information, such as the timing of infection and compartment colonization.
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Introduction
Human cytomegalovirus (HCMV) is a b-herpesvirus with
seroprevalence of 30–90% in the United States [1]. In healthy
individuals, primary HCMV infection is usually asymptomatic or
causes a mild febrile illness. However, in the immuno-compro-
mised or immune-naı¨ve host, HCMV infection can lead to more
severe outcomes, such as graft rejection or death. In particular, an
estimated 0.7% of live-born infants per year (30,000 in the U.S.)
are diagnosed with congenital CMV infection, and nearly 20%
exhibit permanent neurologic sequelae [2].
HCMV has been shown to be highly polymorphic both
among and within human hosts [3–6], and previous studies have
used inter-host or inter-species divergence data to infer the
evolutionary path of HCMV (and other herpesviruses) over long
timescales (thousands to millions of years) [7–10]. These studies
have shown that the virus is well-adapted to its natural host,
using an impressive array of immune evasion and modulation
genes to establish life-long infections [10,11]. However, the
possibility that the virus evolves within human hosts on much
shorter timescales has been poorly studied. Importantly, it has
recently been shown that HCMV genomic and genetic
populations are highly polymorphic, with levels of intrahost
diversity comparable to those observed in RNA virus popula-
tions [5,6]. Because variation is the substrate upon which
selection can act, it is possible that intrahost variation of HCMV
populations allows for rapid evolution within the human host
across relatively short timescales.
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To better understand this process, we used high throughput
sequencing to sample HCMV genomic populations from the urine
and plasma of 5 infants with symptomatic congenital HCMV
infection at multiple time points during the first year of age. This
approach allowed us to monitor genome-wide evolution of the
virus and to determine the mechanisms that contribute to
pathogen evolution. We find that HCMV populations can evolve
slowly within the same tissue compartment, or rapidly when
moving between compartments. In order to characterize the mode
and tempo of this differentiation, we constructed detailed maps of
the in vivo demographic history of HCMV populations, and tested
for signatures of positive selection. In total, this work provides the
most complete insight to date into the evolutionary paths of a
DNA virus as well as the mechanisms that guide these routes in
human hosts.
Results
Our previous work showed significant variability within HCMV
populations sampled from the urine of congenitally infected
neonates - variation that could potentially enable rapid evolution
of the viral population [6]. To study the evolution of HCMV in
human hosts, HCMV genomic populations were examined within
fluid specimens from 5 infants with symptomatic congenital
infection. Specimens were longitudinally collected from the urine
(patients B101, MS1 and MS2), plasma (patient M103) or both the
urine and plasma (patient B103) during the first year after birth (14
specimens in total) (Table 1). Patients B101, M103 and B103 are
unrelated, while patients MS1 and MS2 are monozygotic,
monochorionic twins. A previously described high throughput
sequencing strategy [6] was used to study the viral populations.
Briefly, HCMV genomic DNA was specifically amplified through
a series of PCR reactions, the amplified DNA pools were
sequenced, and the sequence output was analyzed for variants
within and among viral populations. Due to improvements in high
throughput sequencing technology since our initial report, the
frequencies at which variants are detected has improved from
$1.9% [6] to $1.02% and the error rate after filtering has
improved from 6.7% [6] to 5.0% (Figure S1). An average of 854
megabases of sequence information was produced for each of the
14 specimens (Table S1). The sequence data covered an average of
85% of the genome to an average depth of 1921 genome
equivalents (Table S1). The high depth and coverage allows for
quantitative description of the evolution of the HCMV in vivo
populations.
Initially, the populations were studied separately by quantifying
the intrahost variation of each population. Consistent with
previous work, thousands of single nucleotide polymorphisms
(SNPs) were observed in each population (Table 2). On average,
,5,400 SNPs were identified per population, which accounts for
,3% of the positions in the viral genomes sequenced. Similar
levels of variability existed at both the nucleotide and amino acid
levels. To quantify the variability of the populations, nucleotide
diversity values were estimated from the sequence data. These
values were comparable to previous work [6], with a mean
nucleotide diversity value of 0.12% across all populations. There
was a negative correlation between nucleotide diversity of the viral
population and time of sample collection, though the correlation
was not significant (data not shown). However, a significant
correlation was found between nucleotide diversity and the
compartment from which the population was sampled
(P= 0.046, Mann-Whitney), with urine populations exhibiting
lower diversity levels than plasma populations (Figure 1).
To better understand the patterns of sequence variability, the
HCMV genomic populations were studied as pairs across time or
compartments. Eight pairings were created for host-matched
specimens, and the frequencies of all SNPs were tracked across the
pairings (Figure 2, Figure S2). A complex picture of HCMV
evolution emerged from this analysis. For most SNPs, the
frequency was either high or low and remained stable between
paired specimens (seen as black bands at the top or bottom of the
panels). This pattern was observed in all pairings but was most
apparent in longitudinal tracking of SNPs in urine populations
(Figure 2, Panel A). Indeed, for the 36,131 SNPs tracked for all
specimens, 31,919 (88%) changed in frequency by #10% (median
change = 1.14%). This pattern suggests that the frequencies of the
majority of SNPs in these HCMV populations are stable. Figure
S2 shows that the populations with the most stable SNPs
trajectories (slopes<0) also appear to have the largest population
sizes as measured by viral load (e.g. urine compartment
populations) (Table 1). This pattern is consistent with the
relationship of drift and population size, in which the effect of
drift on the frequencies of neutral SNPs is inversely proportional to
population size [12–14]. In contrast, subsets of SNPs were
observed to rise from low frequency to high frequency or vice
versa. This pattern is most apparent when comparing populations
sampled across compartments (for example Figure 2, Panel C).
Lastly, specimens were collected at 3 time points from patients
MS1 and MS2. In these populations, 0.5% of SNPs changed
frequency by $50% between each time point, moving from low to
high to low or vice versa (seen as ‘‘V’’ or inverted ‘‘V’’ patterns in
Figure 2, Panel D; Figure S2, Panel H). These patterns suggest
that HCMV populations are dynamic and do not completely
stabilize in congenitally infected patients during the first year after
birth.
A consensus sequence was then called for each sampled
population. The consensus sequences of two populations of
interest were aligned and SNPs identified between the sequences
(Table 3 and Figure 2, Panels E–H). Phylogenetic trees were also
constructed from all consensus sequences in this study (Figure 3).
Longitudinal specimens collected from a single compartment of a
single host were closely related as indicated by few SNPs between
Author Summary
The large, dsDNA virus Human cytomegalovirus (HCMV) is
the most genetically complex viral pathogen of humans.
HCMV populations are highly variable, which may allow
the virus to evolve in human hosts on short timescales. We
tested this hypothesis by longitudinally sampling HCMV
populations from the urine and/or plasma of congenitally
infected infants. We found that HCMV is generally stable
within a compartment, but rapidly evolves when crossing
host compartments. In fact, HCMV sampled from two
compartments of the same host is as different as HCMV
collected from unrelated hosts. We used mathematical
modeling and population genetic analysis to show that
both a bottleneck (i.e., a reduction in population size)
associated with compartment colonization as well as
positive selection are necessary to explain the observed
differences between compartments. We also conclude
from these data that fetal infection in these patients
occurred between 13–18 weeks gestational age, consistent
with the timing of symptomatic congenital HCMV infec-
tions. This study is the most detailed investigation of DNA
virus evolution in human hosts to date, provides a
framework for the study of other viral infections using
similar techniques, and will aid in the development of new
antiviral therapies and vaccines.
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consensus sequences and short branch lengths on the phylogenetic
tree. For example, 49 consensus sequence SNPs were identified
between the two B103 urine populations, 20 of these SNPs were
non-synonymous. Thus, the consensus sequences differed by only
0.02% at the nucleotide level (p) and 0.04% at the amino acid level
(pAA) (Table 3). A similar result was observed for longitudinally-
sampled plasma populations. For the MS1 and MS2 twins, an
average of 149 SNPs (0.08% difference) was identified between
urine specimen consensus sequences at the same time point and all
MS1 and MS2 sequences clustered together on the phylogenetic
tree. In contrast, for infant B103, an order of magnitude increase
in the prevalence of consensus sequence SNPs was identified
between urine and plasma populations at the same time point.
Comparing the consensus sequences of the urine and plasma
populations, 1,602 SNPs (,0.9% difference at the nucleotide and
amino acid levels) were identified at 1 week, and 1,771 SNPs
(,1.2% difference) were identified at 6 months. Previously, we
have shown that HCMV consensus sequences from different hosts
differ by ,1.1% [6]. Further, the B103 plasma sequences are
clearly distant from the B103 urine sequences on the phylogenetic
tree (Figure 3). Intriguingly, the urine samples appear as a
divergent group on the tree, with B101 sequences being an outlier
in this grouping, while the plasma sequences from the two
unrelated hosts are closely clustered. This result is consistent with
convergent evolution acting on HCMV plasma populations,
though the conclusion is tentative given the small sample size.
Taken together, these results suggest that HCMV collected from
different compartments of a single host are as divergent, or even
more divergent, than HCMV collected from unrelated hosts, but
that sequences sampled longitudinally from the same compart-
ment of the same host or from monozygotic, monochorionic twins
are similar.
In the above analysis, comparisons were made between
consensus sequences, which incorporate only high frequency
SNPs of the populations. To determine if similar levels of
differentiation were present for comparisons of all SNPs, FST
[15,16] was estimated for the specimen pairings. FST is a statistic
bounded by 0 and 1 that increases with increasing variation in
SNP frequencies between populations [17], and is a commonly to
measure differentiation between two populations of the same
species [18]. In this study, FST was used to summarize population
differentiation either across time or compartments. FST values of
the viral populations in longitudinal populations sampled from
urine or plasma compartments were low (average = 0.13, range
[0.05–0.23]) (Figure 3, Table 3). Thus, SNP frequencies were
generally stable within compartments during the sampling time
frame, giving statistical support to the observations from Figure 2.
It is noted that the longitudinal FST values for MS1 and MS2
populations (which were sampled over the longest timespan) rose
with the last collection time points (Figure 3). It is unclear whether
this trend continued or reached a plateau as no later specimens
were available. The highest FST values, and thus the largest
population differentiation, were observed for infant B103 when
comparing populations sampled from different compartment
specimens (urine and plasma) collected at the same time point
(Figure 3, Table 3). FST was equal to 0.42 at 1 week and 0.45 at 6
months. These values are similar to those estimated between
HCMV populations of two unrelated hosts (specifically, urine
specimens from infants U01 and U04 that were described
previously [6]) – thus, within host compartment differentiation can be
as great as between host differentiation (Figure 3).. These results
corroborate the consensus sequence analysis, and suggest that
HCMV populations rapidly differentiate between compartments
of a single host, but are generally stable over time within the same
compartment of a single host or between monozygotic, monocho-
rionic twins.
These data led us to explore the mechanisms of both the
population stability and rapid differentiation of the HCMV
populations observed in this study. From population genetics, it
is known that both demography and selection can lead to large
changes in SNP frequencies in relatively short timespans [19].
Demographic events are changes of population size and structure,
such as population bottlenecks, expansions and splits, which can
lead to stochastic changes in allele frequencies. In contrast,
selection is mediated by variations in fitness associated with
Table 1. Patient and specimen information.
Patient1,2 Specimen Source
Age at Specimen Collection
(months or as noted) Viral Load (copies/mL)
B101 Urine 7 1.3E+07
B101 Urine 10 1.8E+07
B103 Urine 1 week 6.7E+06
B103 Urine 6 2.6E+07
B103 Plasma 1 week 6.9E+04
B103 Plasma 6 4.9E+04
M103 Plasma 1.5 1.8E+04
M103 Plasma 5 3.9E+04
MS1 Urine 1 5.0E+07
MS1 Urine 2 6.4E+06
MS1 Urine 11 4.0E+05
MS2 Urine 1 3.7E+07
MS2 Urine 2 1.0E+07
MS2 Urine 11 4.5E+05
1All specimens were collected from patients with confirmed congenital HCMV infections.
2Patients MS1 and MS2 are monozygotic, monochorionic twins.
doi:10.1371/journal.pgen.1003735.t001
Intrahost Evolution of Human Cytomegalovirus
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different alleles and can cause deterministic changes in allele
frequency.
The high throughput sequence data was analyzed to infer the
demographic history of the viral populations using the statistical
framework described previously [20]. This method estimates the
parameters of a demographic model by solving the appropriate
diffusion equations. This approach has been used to study the
demographic history of higher organisms, such as the migration of
humans out of Africa [20]. The maximum likelihood values for the
parameters of the demographic models were estimated, and
uncertainties of the estimates were calculated through non-
parametric bootstrapping (Table S2). Using this method, best fit
demographic models were developed for the viral populations
sampled from the 5 hosts in this study (Figure 4). All population
sizes within the model are reported relative to their ancestral
population (which is set to 1). In support of modeling accuracy,
there was good agreement between the relative population sizes as
calculated from the models and as measured empirically with
qPCR (Tables 1 and S2).
The demographic history was first inferred for the B103-
sampled viral populations given the rapid inter-compartment
differentiation observed. In the best-fitting B103 demographic
model (Figure 4A), an ancestral population experienced a
bottleneck at time 0 and seeded the plasma compartment. The
bottleneck reduced population size by approximately 99.7%. The
resultant population split 10 weeks later, when 0.41% of the
plasma population colonized the urine compartment. The urine
population then expanded nearly 2000-fold by the time of the
initial collection (1 week postnatally). The urine population
continued to expand, growing 4-fold by the second collection at
6 months. In the plasma compartment, the viral population stayed
relatively stable throughout the model, increasing in size by
approximately 22-fold from the initial bottleneck to the first
collection and decreasing by 45% by the 6 months collection. The
model also includes asymmetrical migration between the com-
partments, with 9-fold higher flow of alleles from the urine to the
plasma before the first collection and 15-fold higher flow before
the second collection (Table S2).
The B101 and M103 best-fit models appear to agree
qualitatively with that of B103 with respect to the demographic
histories of in vivo viral populations (Figures 4B and 4C). B101 and
M103 viral populations also experienced bottlenecks at time 0 that
reduced population size by 99.1% and 99.8%, respectively (Table
S2). For B101, the population experienced a second bottleneck
approximately 11 weeks after the initial bottleneck, which reduced
population size by 97.6%. The population then expanded and
increased in size by ,1100-fold by the first urine collection (7
months) followed by an additional increase of ,1.4-fold by the 10
month collection. For M103, the viral population experienced a
more modest expansion after the initial (and only detected)
bottleneck, increasing in size by ,140-fold and 2.4-fold by the
plasma collections at 1.5 and 5 months after birth, respectively.
Table 2. Genome wide summary statistics for HCMV populations.
Patient Sample Source Time of Collection SNPs P1 Nonsynonymous SNPs PNon
2 PSyn
2
B101 Urine 7 months 6,765 0.17% 4,280 0.11% 0.04%
B101 Urine 10 months 5,019 0.13% 3,153 0.07% 0.02%
B103 Urine 1 week 6,350 0.10% 3,736 0.05% 0.02%
B103 Urine 6 months 6,723 0.10% 3,776 0.05% 0.02%
B103 Plasma 1 week 4,890 0.21% 2,606 0.09% 0.09%
B103 Plasma 6 months 5,735 0.17% 3,181 0.09% 0.04%
M103 Plasma 1.5 months 3,503 0.14% 2,272 0.06% 0.04%
M103 Plasma 5 months 3,820 0.12% 2,308 0.07% 0.03%
MS1 Urine 1 month 5,049 0.09% 2,580 0.04% 0.02%
MS1 Urine 2 months 4,693 0.09% 2,475 0.04% 0.02%
MS1 Urine 11 months 5,515 0.13% 2,978 0.04% 0.03%
MS2 Urine 1 month 4,662 0.09% 2,590 0.04% 0.02%
MS2 Urine 2 months 3,950 0.08% 2,008 0.03% 0.02%
MS2 Urine 11 months 8,789 0.13% 4,870 0.06% 0.03%
1P is nucleotide diversity as calculated using the formula of Nei and Li [45].
2PNon is amino acid diversity and PSyn is the diversity of synonymous SNPs. Both were calculated in the same way as P but only using nonsynonymous or synonymous
SNPs, respectively.
doi:10.1371/journal.pgen.1003735.t002
Figure 1. HCMV population diversity is correlated with host
compartment. Box and whisker plots of the nucleotide diversity of
HCMV populations sampled from the urine and plasma compartments.
The boxes mark the interquartile values and the whiskers show the
minimum and maximum values. The distributions are significantly
different (P= 0.046, Mann-Whitney U, denoted by *), with urine
populations exhibiting lower diversity values than plasma populations.
doi:10.1371/journal.pgen.1003735.g001
Intrahost Evolution of Human Cytomegalovirus
PLOS Genetics | www.plosgenetics.org 4 September 2013 | Volume 9 | Issue 9 | e1003735
Next, a best-fit demographic history was inferred from the MS1
and MS2 sequence data (Figures 4D–E, Table S2). This model
differed from the previous models in several substantial ways. First,
the initial bottleneck did not occur at time 0, but rather at 0.466
months after time 0 (i.e. the earliest event inferred in the model).
Second, the previous models of populations sampled from the
urine compartments (B101 and B103) contained 2 bottlenecks in
the population histories, while the best-fit model of MS1 and MS2
contained 3 bottlenecks, with the first bottleneck shared between
the twins. Of note, the first 2 bottlenecks of the MS1 and MS2
model occurred sequentially, with contiguous confidence intervals
for the timing of the bottlenecks (Table S2). In addition, these
bottlenecks were less severe than those from other models, but the
net effect of the 2 sequential bottlenecks was to reduce population
size by 95% and 92% in the MS1 and MS2 lineages, respectively.
Together, these reductions in population size are comparable to
those inferred in the other models for a single bottleneck. Possible
causes for the disagreements between the models are relayed in the
Discussion.
From the demographic model, some or all of the differentiation
across compartments may be explained by a bottleneck effect
associated with plasma populations colonizing the urine compart-
ment, such as shown in Figure 4A. However, positive selection
may also contribute to rapid differentiation due to the fixation of
advantageous alleles as the virus moves to a new host environment.
To test for evidence of positive selection within HCMV
populations, the population branch statistic (PBS) [21] was
employed. PBS measures localized increases in population
differentiation between two closely related populations and a
third outlier population [21], with larger PBS values indicative of a
higher probability that positive selection has locally altered SNP
frequencies. The test has high power to detect recent positive
selection, particularly when the selected SNP rises from standing
variation [21], an important consideration for this work. An
HCMV population sampled from an unrelated host (described
previously [6]) was used as the outlier in this study, and simulations
under the demographic models in Figure 4 were used to determine
the 5% significance threshold (Figure S5).
The results of this analysis show that the effect of positive
selection in shaping HCMV evolution is variable and dependent
on context. Very few putative targets of positive selection were
identified in the compartment-matched, longitudinal specimens
from all infants (Figures 5 and S3, Tables 4 and S2, S3, S4, S5). In
these populations, an average of 10 total SNPs and 3 non-
synonymous SNPs were identified in the screen. UL7, UL13 and
UL73 (encoding gN) were identified as putative targets of positive
selection in several populations, suggesting that variation in these
genes can affect viral fitness among different hosts. Additionally,
few targets were identified when screening for beneficial SNPs
associated with the urine compartments of monozygotic twins
Figure 2. HCMV populations show patterns of both stability and differentiation. Host-matched specimens were paired either across time
or compartments. The frequency of SNPs was tracked across the pairings. The trajectories show that HCMV populations can be stable, with the
majority of SNPs remaining at nearly the same frequencies over time. A minority of SNPs rapidly change frequencies during the course of sampling,
which is most apparent in panels C and G. Panels A–D: trajectories of all SNPs in the populations. Panels E–H: trajectories of only the consensus
sequence SNPs identified between the pairings. Panels A and E: B103 longitudinal urine populations. Panels B and F: B103 longitudinal plasma
populations. Panels C and G: B103 one week plasma and urine populations. Panels D and H: MS1 longitudinal urine populations. See supplemental
Figure 2 for a complete representation of all pairings used in this study.
doi:10.1371/journal.pgen.1003735.g002
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(MS1 and MS2) (Figure S3, Table 4 and S6, S7, S8, S9, S10, 11),
where on an average 12 total SNPs and 2 non-synonymous SNPs
were identified in each host at the 3 collection time points.
In contrast, the assay yielded significantly different results when
studying positive selection associated with movement of virus
across compartments. The B103 populations sampled from the 1
week urine and plasma specimens were used to estimate the effect
of positive selection associated with colonization of a new host
compartment. 114 SNPs detected in the B103 urine compartment
were identified as putative targets of positive selection, including
31 in non-coding regions and 83 in coding regions (Figure 5,
Tables 4 and S13). The coding SNPs were located in a total of 34
ORFs. Comparison of screens of positive selection (Table 4)
showed that the urine compartment colonization result was a
significant outlier (Grubbs test, P= 6.861024). These data suggest
that positive selection is an important contributor to the rapid
evolution of HCMV populations associated with colonization of
distinct tissue compartments.
Many of the SNPs detected in the screen of selection associated
with urine compartment colonization showed positional clustering
(Figure S4), suggesting that only a few SNPs were positively
selected and the remainder were swept to high frequency via
hitchhiking [22,23]. To identify which SNPs associated with
compartment colonization may be targets of selection and not
simply linked neutral variants, the coding SNPs were classified as
synonymous or non-synonymous (the presumed targets of positive
selection). Of the 83 coding SNPs, 26 were non-synonymous
mutations located in 16 ORFs (Tables 4 and S12). Within this
group, several targets have been shown to exhibit strain or inter-
host variability, such as RL5A [24] and UL55 (encoding gB) [25].
Thus, these data extend previous studies of HCMV polymor-
phisms by showing that differentiation can exist within hosts as
well as between hosts, and that differentiation can be driven by
positive selection. Because selection was observed in the urine
compartment (i.e., kidney), these results suggest that the RL5A and
UL55 SNPs offer a fitness advantage in this compartment, possibly
due to their effects on cell tropism as suggested previously [26].
Positively selected nonsynonymous SNPs were also localized to
US2, US3, and US7, which are contained within the US2 through
US11 block of ORFs that are important for immune evasion by
interference of the antigen presentation machinery [27]. Many
ORFs of unknown function were identified in this screen, some
with multiple nonsynonymous SNPs, such as UL124. However,
the functional effects of these identified SNPs are still unknown.
Lastly, it was observed that positively selected SNPs (Tables S4,
S5, S6, S7, S8, S9, S10, S11, S12, S13, S14) were both pre-existing
(i.e., identified in the ancestral population) and newly arising (i.e.,
not identified in the ancestral population). The relative contribu-
tion of each in driving differentiation was calculated using genome
wide data. The analysis showed that both pre-existing and novel
SNPs contribute to HCMV evolution (Figure 6), though there was
a significant difference between the relative contributions of the
two classes (Chi-square, P= 1.4610211). Specifically, pre-existing
SNPs were more frequently identified in longitudinal plasma
populations, while novel SNPs were more prevalent in the cross-
compartment comparisons. In total, these results suggest that both
pre-existing and de novo mutations contribute with varying degrees
to the evolution of HCMV within human hosts.
Discussion
HCMV has been shown to exhibit significant inter-host
sequence divergence as well as high levels of intra-host variability.
Here we provide a detailed study of the evolution of HCMV in
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human hosts using specimens collected across tissue compartments
and time. Furthermore, we provide evidence of rapid evolution of
HCMV populations associated with movement of the virus
between host compartments. The rapid divergence can best be
explained by a demographic history that includes population
bottlenecks and expansions, as well as positive selection across a
subset of loci.
This study shows that the evolution of HCMV within human
hosts can proceed in two ways. HCMV populations are relatively
stable within tissue compartments. For example, the urine
Figure 3. HCMV populations are highly differentiated across compartments. High throughput sequence data was generated on HCMV
populations collected from 5 infants from either the urine or plasma compartment or both compartments (patient B103). Panel A: Consensus
sequences were generated from the population data of each sample and maximum likelihood phylogenetic trees were constructed from whole
genome alignments. Sequences longitudinally sampled from the same compartment of the same host clustered together. In contrast, B103
sequences sampled from the urine and plasma at the same time were highly differentiated and clustered more closely with sequences from other
hosts. Intriguingly, plasma sequences from two hosts appeared (M103 and B103) to form a single clade, a result consistent with convergent evolution
acting on plasma populations. Node labels represent bootstrap values from 100 replicates and the tree was rooted with the HCMV reference
sequence (Strain Merlin, Ref Seq ID: NC_006273). Panel B: Population differentiation between the populations was measured by estimating the
summary statistic FST for the specimen pairings. Higher values of FST indicate higher levels of population differentiation. HCMV populations are
relatively stable across time when measuring populations collected from the same compartment of a single host or between monozygotic,
monochorionic twins (MS1 and MS2). B103 populations sampled from different compartments at a single timepoint showed elevated FST values,
indicative of higher levels of population differentiation. The level of differentiation observed between compartments in a single patient is comparable
to that observed between populations collected from unrelated patients. Error bars represent 95% confidence intervals. ANOVA analysis:
P= 6.7610213.
doi:10.1371/journal.pgen.1003735.g003
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populations of B101 and B103 exhibited only 52 and 49 consensus
sequence SNPs, respectively, and low FST values. This result is in
agreement with previous studies that have monitored HCMV
genetic sequences within patients [5,28]. In addition, HCMV
populations were stable across hosts, albeit for the unique case of
monozygotic, monochorionic twins when sampled from the same
compartment. In these cases, demographic modeling suggested
stable population size and structure, and the trajectory of many
SNPs is consistent with the effects of drift.
In contrast, HCMV populations can also rapidly evolve during
colonization of different compartments within a host. Significant
HCMV inter-host differentiation is well documented, both at the
genetic and genomic levels [3,6,24,29,30]. Here we show that a
similar level of differentiation can be observed within different
compartments of a single host (here represented by the plasma and
urine). However, HCMV can be found in many other organs [4]
and bodily fluids (e.g., saliva, breast milk, and semen). While the
large differentiation between compartments and the patterns of
bottlenecks and expansions observed in our study may be unique
to plasma and urine, any movement between other compartments
would likely involve similar demographic histories. Moreover,
each compartment may have unique selective pressures as
reported here for the plasma and urine compartments. It is
therefore probable that most compartments will show levels of
differentiation similar to those reported in this study.
One reason that the plasma and urine compartments were
chosen for study is because they represent the circulating and shed
HCMV populations, respectively. Plasma virus is likely limited to
the individual (with the important exceptions of transfusion/
transplantation-associated and congenital infections) whereas virus
shed into urine is excreted and possibly infecting other hosts. The
results in this work suggest that there are large differences between
viral populations isolated from these two sources. The potential
implications of these findings are numerous. For example, do
studies of secreted virus, such as from the urine and/or saliva,
provide useful information about circulating virus or infection-
associated diseases? In addition, how do SNPs associated with
shedding viral populations (e.g., urine populations) affect tropism
for mucosal surfaces, the presumed route of most inter-host
infections? The evidence for positive selection when crossing into
the urine compartment suggests that the viral population has
adapted for increased fitness, but most likely increased fitness in
renal epithelial cells. Thus, it is not known how compartmental-
ization affects inter-host infectivity. Alternatively, because at least a
portion of the differences between populations could be explained
by the neutral demographic history, some of the SNPs would have
arisen stochastically and may have little or no effect on viral fitness.
Therefore, it will be interesting to determine the phenotypic
differences between patient-derived HCMV populations from
different compartments.
Demographic histories of HCMV populations were generated
from population data in this study. These demographic models
may provide a partial explanation for the population differenti-
ation observed across compartments. The B103 model suggests
that the urine and plasma populations split 3 months prior to the
initial collection. It was also observed that these populations are
Figure 4. Demographic histories of HCMV clinical isolates show evidence of bottlenecks and expansions. The demographic histories of
the viral populations were inferred from the high throughput sequence data. In the models, time increases from left to right and the width of the
various shapes is proportional to the size of the viral populations. All population sizes and timespans are drawn to scale. A tabular representation of
parameter values of the model can be found in Table S2. See the text for a complete discussion of the models. Panel A: Model of B103 sampled
population histories. (The populations within the urine compartment of B103 are drawn to 1:8 scale [as compared to the B103 plasma compartment]
for the sake of clarity.) Panel B: Model of B101 sampled population histories. Panel C: Model of M103 sampled population histories. Panel D: Model of
MS1 and MS2 sampled population histories Panel E: Expansion of early timepoints of MS1 and MS2 model. Arrows drawn between populations
(Panels A and D) represent migration rates and are scaled relative to each other and not population sizes to improve visibility of the arrows.
doi:10.1371/journal.pgen.1003735.g004
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highly differentiated, as measured by FST (Figure 2, Table 3).
From the B103 demographic model, at least a part of this
differentiation may be explained by the strong bottleneck and
large population expansion that occurs as the virus colonized the
urine compartment. The bottleneck would reduce population size,
leading to decreased diversity due to the stochastic elimination of
ancestral SNPs (which likely explains the results shown in Figure 1).
A decreased population size would also increase the speed and
probability of fixation of neutral SNPs [13,14]. Secondly, DNA
replication associated with population expansion could introduce
new mutations to the urine compartment population.
The demographic model generated from B103 data also
suggests a novel mechanism for reinfection. In the model, there
was asymmetric migration of alleles between host compartments
with a higher flow from the urine to the plasma. In this study, the
flow of alleles was relatively low and the plasma population size
was fairly stable. One could speculate that after a collapse of the
plasma population, due the effects of the adaptive immune
response or antiviral therapy, migration between compartments
would provide a source of highly differentiated virus. Thus, a
clinical manifestation of this phenomenon could be intrahost (i.e.
self) reinfection by virus sourced from various compartments. If
this is true, effective HCMV vaccine design will need to account
for not only plasma-associated epitopes but also epitopes sourced
from other compartments. Future studies are needed to test the
validity and prevalence of this mechanism of reinfection, and its
potential effect on anti-HCMV clinical strategies.
An important disagreement was noted between the B101 and
B103 models and those of MS1 and MS2: the best-fit model of
B101 and B103 urine populations contained 2 bottlenecks
separated by ,2.5 months, while the MS1 and MS2 model
contained 3 bottlenecks, separated by 0.2 months and 2.2 months.
One possible explanation for the disagreement is that in some
hosts, HCMV undergoes 2 bottlenecks en route to the urine
compartment, while in other hosts there are 3 bottlenecks.
However, there is no clear biological mechanism to explain this
difference. Alternatively, the MS1 and MS2 models appear to
infer events further back in time than those of the other models.
Thus, the first bottleneck in this model could reflect an earlier
event for which the other datasets had insufficient power to detect.
A third explanation is that the MS1 and MS2 models have higher-
resolution than those inferred from the other datasets. To generate
these models, one compares the spectrum of neutral allele
frequencies of the experimental dataset to the spectra that would
be expected from populations that have experienced various
demographic events (i.e. bottlenecks and/or expansions). The best
fit model is one for which the experimental spectrum most closely
matches the expected spectrum. Unfortunately, models of various
population histories could generate similar allele frequency
spectra, limiting the ability to fully resolve these models. However,
because MS1 and MS2 viral populations were derived from the
same ancestral population, two allele frequency spectra were
estimated from populations that evolved in parallel from the same
ancestor, providing more information about the evolutionary
history of the populations and allowing similar models to be
resolved. Thus, it is proposed that all HCMV urine populations
have experienced at least 3 bottlenecks prior to colonization of the
kidney. However, two bottlenecks may not be resolved by data
from a single host due to the very close timing of the bottlenecks
(,1 week). The net effect of both bottlenecks is reduction of
population size by .90% (Table S2).
If three bottlenecks do indeed occur during the course of
HCMV congenital infections, the biological cause of these
reductions in population size is not known. We hypothesize that
the first bottleneck results from the movement of the virus from the
maternal compartment to the placenta. In all models, the timing of
this event was ,13–18 weeks gestational age and appears to agree
with the known epidemiology and pathology of symptomatic
HCMV congenital infections [31–33]. In the MS1 and MS2
models, the first bottleneck is shared and followed by a ,1 week
period in which the viral population expanded ,4-fold before
splitting and entering the separate, second bottlenecks of the two
infant lineages. We propose that these events reflect replication of
the virus in the twin’s shared placenta, followed by independent
infection of the fetal circulatory compartments. Replication of
HCMV in placental cytotrophoblasts has been demonstrated
experimentally [34], and the data presented here offer a novel
method to support the hypothesis that HCMV replicates within
the placental compartment. We further hypothesize that the third
bottleneck in the history of the urine populations represents
movement of the virus from the plasma to the renal compartment,
which occurred ,9–11 weeks after the initial fetal infection event.
Whether the timing and extent of the bottlenecks is consistent
across HCMV congenital infections or differs between symptom-
atic and asymptomatic infections still needs to be studied.
Nevertheless, our work demonstrates that viral demographic
histories can be clinically informative for understanding viral
infections.
From the data in this study, it is tempting to speculate on the
relative contribution of demography and selection to the evolution
of HCMV populations. For example, 1602 SNPs were observed
between the B103 urine and plasma compartment consensus
sequences at 1 week of age (Table 3), of which 114 were putative
Figure 5. Positive selection plays a variable role in HCMV in
vivo evolution. The population branch statistic (PBS) was used to
identify putative targets of positive selection within the HCMV viral
populations collected from congenitally infected infants. Higher PBS
values identify loci that have a higher likelihood of being targets of
postive selection. The red line indicates the 5% significance threshold,
above which values are considered significant. This threshold was
determined through simulations using the demographic parameters
inferred from the data, as depicted in Figure 4 and Table S2. See Tables
S4, S5, S6, S7, S8, S9, S10, S11, S12, S13, S14 for tabular presentations of
these data. Panel A: longitudinal B103 urine populations. Panel B: B103
longitudinal plasma populations. Panel C: B103 1 week plasma and
urine populations. For the results of all PBS analyses, see Figure S3.
doi:10.1371/journal.pgen.1003735.g005
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targets of positive selection (Table 4). One could propose that
,7% of SNPs rose in frequency due to positive selection (either
directly or via linkage), and the remainder were governed by
genetic drift. However, caution must be used with these estimates.
For example, a demographic model was first fit to the data, and
then the signatures of positive selection were detected, which may
result in over-fitting the demographic model [35]. Second, the test
of positive selection may have excluded SNPs because of missing
data due to incomplete coverage of the outlier group. Third, the
time course of selection may overlap poorly with the time course of
sample collection. For example, a SNP may have arisen from very
low frequency to become fixed due to strong selection. A changing
selective environment may have reduced or eliminated the
selective advantage, allowing the SNP to drift to a lower frequency
in the population. If the timing of sampling does not overlap the
timing of selection, the SNP would not be identified as a target of
positive selection. Thus, we are limited in our ability to accurately
quantitate the relative contribution of demography and selection
to the evolutionary patterns observed in this study. However, it is
very reasonable to state based on the data as a whole that both
demography and positive selection influence the intrahost
evolution of HCMV, and thus both need to be accounted for in
future studies of the natural history of HCMV and other viral
infections.
Materials and Methods
Ethics statement
The use of specimens from subjects B101, B103, and M103 was
approved by the University of Massachusetts Medical School and
Baystate Medical Center Institutional Review Boards. Subjects
MS1 and MS2 clinical specimens were obtained from neonates
with congenital HCMV infection during the course of routine
clinical care at the University of Minnesota Medical School.
Protocols for collection of HCMV isolates from congenitally
infected infants were approved by the University of Minnesota
Institutional Review Board. Informed consent was obtained from
subjects’ parents for study of HCMV.
Patient population, collection of specimens and viral
DNA extraction
Patients identified at the University of Minnesota Medical
Center or University of Massachusetts Memorial Health Center
were evaluated for HCMV infection on the basis of signs and
symptoms suggesting congenital infection. Patients MS1 and
MS2 were monochorionic, monozygotic twins with clinical
evidence of congenital CMV consisting of thrombocytopenia,
transaminitis, and, for MS1, a small gestational age phenotype.
Congenital infection was confirmed for all patients by urine
HCMV positive cultures before 3 weeks of age and/or PCR
detection of HCMV DNA. No patients were treated with
antiviral drugs.
Serial specimens were collected at times described in Table 1.
Specimens were stored at 280uC until DNA purification. Total
DNA was purified using a Qiagen Blood and Tissue Kit using the
standard protocol.
Amplification of HCMV DNA
A set of primer pairs were constructed that spanned the entire
HCMV genome. Details of the primers sequences and primer
design strategy have been described [6]. The conditions for PCR
were as follows: 16PfuUltra II PCR buffer, 0.25 mM each dNTP
(NEB), 0.25 uM each primer (IDT DNA), 0.5 uL PfuUltra II
Polymerase (Agilent) and 1M betaine. A touchdown PCR was run
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on an Eppendorf Mastercycler ep gradient S with the following
program for all reactions: 98uC for 2 min, 5 cycles of 98uC for
30 s, 63uC (decreasing by 1u/cycle) for 30 s, 72uC for 2 min,
followed by 25 cycles of 98uC for 30 s, 58uC for 30 s and 72uC for
2 min, with a 10 min final extension at 72uC. Approximately
10,000 genomes copies, based on qPCR results, were used for each
amplification reaction. All amplified products were size-selected on
agarose gels and gel purified. After amplification of the HCMV
genome, all amplicons were quantified on a Nanodrop 2000,
pooled in equimolar proportions and used as substrate in Illumina
sequencing. Quantitative PCR was performed using primers and
probes described previously [36].
Figure 6. Pre-existing and new SNPs contribute to varying degrees to HCMV evolution. Panel A: Consensus sequence SNPs between
populations were classified as either pre-existing (detected in the ancestral and derived populations) or new (only detected in the derived
population). Plotted are the occurrence of these two classes of SNPs in the various patient specimens. Panel B: A tabular representation of the data
presented in Panel A.
doi:10.1371/journal.pgen.1003735.g006
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Illumina sequencing
The DNA in pooled amplicons was sheared by sonication on a
Sonic Dismembrator 550 (Fisher) until the median size was ,350
basepairs (bp). The DNA library was prepared as described [37].
Briefly, DNA was end-repaired using the End-Repair Enzyme Mix
(NEB), and A-tailed using the ATP and Klenow (exo2) (NEB).
Adapters with appropriate barcodes were ligated onto the
modified DNA ends. The library was then size selected on a 2%
agarose gel, to produce a library with a median size of 350 bp+/
250 bp. The library was amplified with Illumina primers (P/N
1003454) (www.illumina.com). Once prepared, the libraries were
combined in appropriate ratios and submitted for paired-end
sequencing on the Illumina GAII. A Toledo strain amplicon set
generated from a BAC clone was included as an internal control
for measuring error rates.
Sequence analysis
The raw sequence images were processed through Illumina
Pipeline 1.8 to generate sequence data. The consensus sequence of
each sample was called as described [6]. Variants from the
consensus sequence were called using the variant filtering protocol
as described previously [6]. The variants were filtered to remove
errors using parameter thresholds. Variants with parameters below
the thresholds were discarded. The thresholds were: minimum
basecall quality ($33), mapping quality ($89), and depth ($15).
Variant frequency was also used as a threshold. In our prior work,
a variant frequency threshold of $1.9% was used. However, due
to reduced error rates associated with Illumina sequencing, a lower
variant frequency threshold of $1.02% could be used to achieve a
5% false positive rate (Figure S1). Unfolded SNP frequency spectra
were generated using the HCMV reference sequence (Strain
Merlin, Ref Seq ID: NC_006273) as an outgroup for the intrahost
populations under study.
Whole genome alignments were generated using the Vista
whole genome aligner hosted on the Vista server [38]. Maximum
likelihood trees were constructed using PhyML software [39] with
an HKY85 substitution model, transition/transversion rates
estimated from the data, and 100 bootstrap replicates.
Modeling of demographic history of HCMV populations
A dataset of only synonymous mutations for each viral
population was created. These datasets were used as neutral
datasets for subsequent analysis of demographic history and were
analyzed with the program dadi (Diffusion Approximation for
Demographic Inference) [20] to build demographic models and
yield maximum likelihood estimates of the parameters of the
models. SNP frequency data from the pooled sequencing data was
projected down into 15 bins, which is the minimum sequencing
depth required for SNP calling. For the M103 and B101
populations, samples were collected at two time points from a
single host and a single compartment. The models built from these
data used the ‘‘frozen’’ function of dadi, in which the model was
constructed with the joint frequency spectrum from both time
points and the early time point sample was ‘‘frozen’’ (no input of
additional mutations and drift ceased) after the collection time
point. Samples collected from B103 were collected at multiple time
points and two compartments, and samples from MS1 and MS2
were collected at 3 time points and two hosts. In these cases, the
models depicted in Figure 4 reflect the best-fit model that was
constructed from the two divergent populations at the final time
point. Specifically, the models were built from the 6 month urine
and plasma samples from B103 and the 11 month urine samples
from MS1 and MS2. However, models were also built using the
earlier time point data from different compartments or hosts (for
example, 1 week urine and plasma from B103) (data not shown).
The earlier time point data were used to build a framework of the
model, which eased the building of the later, more complex model.
Many models were tested, including a standard neutral model and
models excluding migration or alternating the number of
bottlenecks. The alternate models were found to be worse fits to
the experimental data than the models depicted in Figure 4, as
measured by log likelihoods and AIC model comparisons. A fit of
the models are depicted in Figure S5. 95% confidence intervals of
the parameters were estimated using nonparametric bootstrap-
ping. In the resulting models, all times are reported in units of 2N
generations. However, the time between the collection time points
was known (e.g., 1 week to 6 months of age). Timespans were used
to convert all times within the models to calendar time. Migration
rates in the model are given in units of M = 2Nem, where Ne is the
effective population size and m is the number of migrants per
generation. Ne was estimated from the variance in SNP frequency
in time sampled populations using the method of Jorde and
Ryman [40]. The estimate of Ne for all samples was approximately
1000 (mean = 961, range [478–1450]) (Table S3) and this value
was used to convert parameters from the model to units of
migrants per generation.
Test of positive selection
To test for evidence of positive selection, we employed the
population branch statistic (PBS) as described [21]. The PBS
statistic uses a log transformation of the FST statistic to identify
regions of the genome that have an elevated level of differentiation
between closely related populations. Positive selection acting on an
allele would be predicted to locally increase FST at the site of the
selection, and thus, lead to an increase in the PBS statistic in this
region. Importantly, FST-based tests show high power to detect
selection from populations with high levels of standing variation
[41,42]. This was an important characteristic for a test of selection
because we have previously shown that HCMV populations
collected from congenitally infected neonates are highly variable.
We also employed a test of selection that searched for localized
regions of reduced variability and an excess of surrounding high
frequency alleles [43]. This pattern is expected when selection has
recently acted upon a new mutation from a population with low
mutation rates. This test identified fewer targets of selection within
these data, but there was high concordance between this test and
the PBS statistic (data not shown).
To determine the significance of the PBS statistic, 10,000
simulations were run for a 5,000 bp region under the inferred
demographic histories of the populations (Figure 4) using the
forward simulator sfs_code [44]. Simulation of a full length HCMV
genome (,235,000 bp) was computationally intensive and re-
quired a prohibitively long time to complete. For this reason,
sequence length in the simulation was set to be similar to an
average HCMV gene with surrounding regulatory elements,
following a previously described approach [21]. The 10,000
iterations were analyzed as a complete dataset, and each position
contained at least 1 SNP. The SNP at each position (5,000 in total)
with the maximum PBS value was identified from the simulations
(Figure S6). The results from the simulations were then compared
to the experimental data to determine the 5% significance
threshold of the PBS values and the corresponding P values of
all SNPs with significant (P,0.05) PBS scores.
Availability of data
Raw sequencing reads from Illumina sequencing will be
deposited in the Sequence Read Archive (http://www.ncbi.nlm.
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nih.gov/Traces/sra/sra.cgi). Data will be available upon publica-
tion.
Supporting Information
Figure S1 SNP calling false positive rate (FPR) is dependent on
filtering threshold. A filtering algorithm that has been described
previously [6] was employed to reduce false positives when calling
SNPs from high throughput sequence data. A parameter of the
filtering is SNP frequency threshold, such that SNPs with
frequencies below the threshold are excluded. Here is plotted
the relationship between the FPR and the frequency threshold
values used in filtering. These values were calculated by
sequencing a BAC clone, which was assumed to contain no
polymorphisms and all errors were assumed to be amplification or
sequencing errors.This relationship was plotted for three average
sequencing depths (6506, 15006 and 30006). The dotted black
line represents a 5% FPR.
(TIF)
Figure S2 HCMV populations show patterns of both stability
and differentiation. Full panel of results from those depicted in
figure 2. Plotted here are the trajectories of SNPs between sample
pairings. Panels A–H: trajectories of all SNPs in the populations.
Panels I–P: trajectories of only consensus SNPs identified between
the pairings. Panels A, I: B101 longitudinal urine samples. Panels
B, J: B103 longitudinal urine samples. Panels C, K: M103
longitudinal plasma samples. Panels D, L: B103 longitudinal
plasma samples. Panels E, M: B103 1 week urine and plasma
samples. Panels F, N: B103 6 month urine and plasma samples.
Panels G, O: MS1 longitudinal urine samples. Panels H, P: MS2
longitudinal urine samples.
(TIF)
Figure S3 Evidence of positive selection in HCMV samples. Full
results of PBS tests from Figure 5. The population branch statistic
(PBS), a measure of the signature of positive selection, was plotted
across the HCMV genome. Higher values are indicative of a
higher probability of a region being the target of the positive
selection. Red dotted line represents the 5% significance threshold.
Panel A: longitudinal B101 urine samples. Panel B: longitudinal
B103 urine samples. Panel C: longitudinal M103 plasma samples.
Panel D: longitudinal B103 plasma samples. Panel E: B103 1 week
urine and plasma samples. Panel F: MS1 1 month urine sample.
Panel G: MS1 2 month urine sample. Panel H: MS1 11 month
urine sample. Panel I: MS2 1 month urine sample. Panel J: MS2 2
month urine sample. Panel K: MS2 11 month urine sample.
(TIF)
Figure S4 Targets of positive selection are clustered on the
HCMV genome. SNPs from the B103 urine sample were
identified as putative targets of positive selection. Plotted as a
histogram are distances between putatively selected SNPs. The
majority of putatively selected SNPs are located within 200
basepairs of the nearest selected SNP.
(TIF)
Figure S5 Comparison of demographic models to population
data. Joint allele frequency spectra of the population data (top left
of each panel) are compared to the expected joint allele spectra of
the demographic models depicted in Figure 4 (top right of each
panel). Residuals between the population data and demographic
models are plotted as frequency spectra (bottom left of each panel)
or as histograms (bottom right of each panel). Log likelihood of the
models are shown at the top of each panel. Panel A: B103 Panel B:
B101 Panel C: M103 Panel D: MS1 and MS2.
(TIF)
Figure S6 Results of simulations under demographic models
depicted in Figure 4. 10,000 simulations were run for a 5,000
basepair region under the inferred demographic histories of the
populations (Figure 3) using the forward simulator sfs_code [44].
The SNP at each position (5,000 in total) with the maximum
PBS value was identified from the simulations. The 5%
significance thresholds for each simulation set are shown as
red lines. Panel A: longitudinal B101 urine samples. Panel B:
longitudinal B103 urine samples. Panel C: longitudinal M103
plasma samples. Panel D: longitudinal B103 plasma samples.
Panel E: B103 1 week urine and plasma samples. Panel F: MS1
1 month urine sample. Panel G: MS1 2 month urine sample.
Panel H: MS1 11 month urine sample. Panel I: MS2 1 month
urine sample. Panel J: MS2 2 month urine sample. Panel K:
MS2 11 month urine sample.
(TIF)
Table S1 Summary of sequencing data.
(PDF)
Table S2 Parameter values of demographic models HCMV
populations.
(PDF)
Table S3 Estimate of HCMV effective population size from time
sampled populations.
(PDF)
Table S4 Targets of positive selection in 6 month B103 plasma
populations.
(PDF)
Table S5 Targets of positive selection in 6 month B103 urine
populations.
(PDF)
Table S6 Targets of positive selection in 10 month B101 urine
populations.
(PDF)
Table S7 Targets of positive selection in 5 month M103 plasma
populations.
(PDF)
Table S8 Targets of positive selection in MS1 1 month urine
populations.
(PDF)
Table S9 Targets of positive selection in MS2 1 month urine
populations.
(PDF)
Table S10 Targets of positive selection in MS1 2 month urine
populations.
(PDF)
Table S11 Targets of positive selection in MS2 2 month urine
populations.
(PDF)
Table S12 Targets of positive selection in MS1 11 month urine
populations.
(PDF)
Table S13 Targets of positive selection in MS2 11 month urine
populations.
(PDF)
Table S14 Targets of positive selection in 1 week B103 urine
populations.
(PDF)
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